Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
186.95
-0.63 (-0.34%)
At close: Nov 14, 2025, 4:00 PM EST
187.60
+0.65 (0.35%)
Pre-market: Nov 17, 2025, 8:27 AM EST
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.82B in the quarter ending September 30, 2025, with 13.18% growth. This brings the company's revenue in the last twelve months to $10.85B, up 13.74% year-over-year. In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth.
Revenue (ttm)
$10.85B
Revenue Growth
+13.74%
P/S Ratio
1.93
Revenue / Employee
$193,750
Employees
56,000
Market Cap
20.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
DGX News
- 2 days ago - Quest Diagnostics Incorporated (DGX) Presents at 7th Annual Healthcare Symposium Transcript - Seeking Alpha
- 2 days ago - Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Daily Dividend Report: ADP, Agree Realty, Group 1, DGX, Aflac - Forbes
- 5 days ago - Quest Diagnostics Declares Quarterly Cash Dividend - PRNewsWire
- 13 days ago - Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference - PRNewsWire
- 21 days ago - New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis - PRNewsWire
- 25 days ago - Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead - Seeking Alpha
- 25 days ago - Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings - Benzinga